Contract 1455612

The State of Nebraska Department of Health and Human Services awarded a contract to GlaxoSmithKline Pharmaceuticals for pharmaceutical payments effective August 20, 2026. The contract, designated as Contract Type ZO, carries a total contract amount of $98,803.60. The award and completion date coincide on August 20, 2026, indicating a single-day transaction or payment execution. This award represents a pharmaceutical supply or medication procurement arrangement typical of state health department operations supporting Medicaid or public health programs.

GlaxoSmithKline Pharmaceuticals, as the prime contractor, was selected to provide pharmaceutical products or related payment services under this Nebraska state contract. The contract's brief performance window and specific dollar amount suggest this may represent a supplemental pharmaceutical acquisition, a targeted medication supply for a specific program, or a payment settlement for pharmaceutical services. No specific county, performance location, or extended performance period beyond the award date has been identified in the available contract documentation.